Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Amy Guisinger's publication output changed over time?
ScholarIQpublication output · 2020–2023
Output declined67% over the shown period — from 3 works in 2020 to 1 in 2023.
3
6
1
202020212023
What are the most-cited papers on Amy Guisinger?
ScholarIQmost cited works
Screening for Vitamin D Deficiency in Adults
Leila C. Kahwati, Erin S. LeBlanc, Rachel Palmieri Weber, Kayla Giger, Rachel Clark, Kara Suvada, Amy Guisinger, Meera Viswanathan
JAMA. 202172 Citations
Assessment of Study Quality
Leila C. Kahwati, Erin S. LeBlanc, Rachel Palmieri Weber, Kayla Giger, Rachel M. Clark, Kara Suvada, Amy Guisinger, Meera Viswanathan
202129 Citations
<p>Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy</p>
Chad Moretz, Ashley L. Cole, George Mu, Benjamin Wu, Amy Guisinger, Yunhao Liu, Beth Hahn, Lee Baylis
International Journal of COPD. 202013 CitationsOPEN ACCESS
Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study
Shirley P. Huang, Amy Guisinger, Carlyne M. Averell, Christopher F. Bell, Bernie Rubin
Rheumatology and Therapy. 202310 CitationsOPEN ACCESS
Abstract PS13-33: Feasibility of a comprehensive monitoring protocol for the prevention and treatment of interstitial lung disease in patients undergoing treatment with fam-trastuzumab deruxtecan
Heather Moore, Scott Shofer, Amy Guisinger, Gloria Broadwater, Jeremy Force, Sarah Sammons, Carey K. Anders, Kelly Westbrook
Cancer Research. 20213 Citations
Related on ScholarIQ
Duke University
Institution
Screening for Vitamin D Deficiency in Adults
Paper
Assessment of Study Quality
Paper
<p>Evaluation of Medication Adherence and Rescue Medication Use in Non-Exacerbating Patients with COPD Receiving Umeclidinium/Vilanterol or Budesonide/Formoterol as Initial Maintenance Therapy</p>
Paper
Clinical and Economic Burden of Systemic Lupus Erythematosus in the Years Preceding End-Stage Kidney Disease Diagnosis: A Retrospective Observational Study
Paper
Abstract PS13-33: Feasibility of a comprehensive monitoring protocol for the prevention and treatment of interstitial lung disease in patients undergoing treatment with fam-trastuzumab deruxtecan
Paper